-
News
- Technology /AI
- Medical journals
- Topics
Growth Disorders
We recommend
Somapacitan administered once weekly in the treatment of children with growth hormone deficiency – current understanding
12. 6. 2024 Source: Growth DisordersSomapacitan is a long-acting derivative of recombinant human growth hormone approved for the treatment of children and adults with growth hormone (GH) deficiency. Dr. Reiko Horikawa from Japan's National Center for Child Health and Development in Tokyo, during the 24th Pediatric Endocrinology Days held in Brno in January 2024, showed that it is a promising therapeutic option for pediatric patients from 3 years of age, thanks to its efficacy, safety, and potential to improve therapy adherence. However, careful long-term monitoring of the…
Cardiovascular System Affection in Children with Noonan Syndrome
Noonan syndrome is a genetically conditioned disease classified among the so-called RASopathies,…13. 12. 2021 Source: Growth Disorders
Prenatal Phenotype of Children with Noonan Syndrome
Until recently, the various phenotypes of RASopathies were clinically diagnosed only after birth.…4. 5. 2021 Source: Growth Disorders
Articles on this topic
Noonan Syndrome (Not Just) in the Pediatric Cardiologist's Office
Noonan Syndrome (NS) is a genetically determined disease associated with a high prevalence of…23. 2. 2021 Source: Growth Disorders
Noonan's Syndrome – History and Present
The genetically determined syndrome linking congenital heart defect with a typical facial…30. 11. 2020 Source: Growth Disorders
Register of Patients Treated with Growth Hormone (REPAR): Data Analysis as a Path to Further Optimization of Care
Treatment with recombinant growth hormone (rhGH) is available in the Czech Republic for all…30. 11. 2020 Source: Growth Disorders
Journal articles How prevalent is being born small for gestational age? Analysis of 7341 children from the ELSPAC study population
25. 2. 2011 Source: Czech-Slovak Pediatrics | 2/2011
Journal articles Prenatal diagnosis of Noonan syndrome in fetuses with increased nuchal translucency and a normal karyotype
24. 4. 2019 Source: Czech Gynaecology | 3/2019
Most read on this topic- Prenatal diagnosis of Noonan syndrome in fetuses with increased nuchal translucency and a normal karyotype
- Noonan's Syndrome – History and Present
- Noonan Syndrome (Not Just) in the Pediatric Cardiologist's Office
- Cardiovascular System Affection in Children with Noonan Syndrome
- Prenatal Phenotype of Children with Noonan Syndrome
- Register of Patients Treated with Growth Hormone (REPAR): Data Analysis as a Path to Further Optimization of Care
Related topicLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Technology /AI